Small NBFC
Market Cap
₹3,692 ₹3,692 Cr.
P/E
43.48
PEG
1.87
PEG = P/E ÷ 5yr Forward EPS CAGR
5yr Forward EPS CAGR Thesis - Base Case

- The thesis comes alive if FY27 consolidated revenue guidance and the dialysis-centre rollout execute as planned, with sickle-cell testing commercialisation validating the later healthcare ramp.- The bull path depends on commercial revenue from Onco Spectra and TB Truth plus successful dialysis execution, while the bear path reflects guidance misses, rollout shortfalls, delayed healthcare adoption or slower renewable-energy order-book conversion.

Get your Reports on Demand
Get detailed, analyst-grade reports with actionable insights to make informed investment decisions.
  Flat 20% OFF
 for Tijori Premium Users
My Reports
  Flat 20% OFF  for Tijori Premium Users
5Y Revenue & EBITDA Estimates
KEY TRIGGERS TO WATCH
  • The thesis comes alive if FY27 consolidated revenue guidance and the dialysis-centre rollout execute as planned, with sickle-cell testing commercialisation validating the later healthcare ramp.
  • The bull path depends on commercial revenue from Onco Spectra and TB Truth plus successful dialysis execution, while the bear path reflects guidance misses, rollout shortfalls, delayed healthcare adoption or slower renewable-energy order-book conversion.
Bear : 9.8% CAGR ₹1,356 Cr
Base: 21.5% CAGR ₹2,263 Cr
Bull: 32.1% CAGR ₹3,434 Cr
Management Credibility Report
TRACK RECORD
  • 7 of 13 promises kept — but every miss clusters in one place : Solar, battery, and green-hydrogen timelines all slipped 18–24 months (H2 pushed ~7 years); the balance-sheet and 5G promises landed on time.
  • The tell : Management hits every target it controls (leverage 0.64x, EBITDA doubled to ₹2.08 lakh Cr, 5G on schedule) and misses every first-of-a-kind build-out — so haircut clean-energy dates by 18–24 months.
  • The number that doesn't add up : Revenue grew 5% but receivables jumped 26% and cash drained to ₹0.46 Cr — growth is turning cash-intensive right before the make-or-break renewal.
Met : 0
Progress: 0
Missed : 0
Risk Probe Report
WORST-CASE SCENARIO
  • 15 of 17 areas flagged High Risk : Negative net worth of ₹(1,00,853) Cr, current ratio 0.05, and eight straight years of qualified audits.
  • The smoking gun : A forensic audit found ₹13,558 Cr diverted to related parties; four banks have declared the account fraud, the ED has attached ₹21,627 Cr, and a ₹61,619 Cr AGR liability now exceeds total debt
  • Rated Existential : If NCLT rejects the resolution plan, liquidation on 2018-era asset values leaves equity holders zero.
High Risk : 0
Medium Risk : 0
Low Risk : 0
Powered By
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material